Meros Polymers among spinoffs and U.S. patent holders celebrated at business incubator TEC Edmonton’s annual event.
A University of Alberta spinoff company looking to unlock an entire class of non-water-soluble drug options—including a number of anti-cancer drugs—was recognized at the TEC Edmonton 2019 Innovation Awards yesterday.
Meros Polymers, formed in 2009 to commercialize advanced drug delivery technologies developed by U of A pharmaceutical sciences professor Afsaneh Lavasanifar, was celebrated along with 10 other burgeoning U of A spinoffs and nine U of A technologies receiving a U.S. patent in the last year, at the technology transfer agent’s annual gala.
“If drugs are not soluble, you cannot inject them because they have to be soluble in the blood,” said Lavasanifar, who published a paper in 2006 on the potential for a drug additive she subsequently patented with the promise of revolutionizing drug delivery. “There are many drug cand...